[
  {
    "sentence": "Growth is usually localised, but it can infiltrate and damage surrounding tissue, which if left untreated can cause considerable destruction and disfigurement, particularly when located on the face (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "People with cSCC often present with an ulcer or firm (indurated) papule, plaque, or nodule (Griffin 2016), often with an adherent crust (Madan 2010) (Figure 1). cSCC can arise in the absence of a precursor lesion or may develop from pre‐existing lesions, such as actinic keratosis or Bowen's disease (considered by some clinicians to be cSCC in situ) with an estimated annual risk of progression of less than 1% to 20% for newly‐arising lesions (Alam 2001) and 5% for pre‐existing lesions (Kao 1986).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The contrast for the monochrome images produced is achieved by the variation of the optical properties within the skin when illuminated by a near‐infrared light (830 nm) (see Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The Vivascope 1500 (and the previously available 1000 version) is a console‐based unit with a dermoscopic attachment, whereas the Vivascope 3000 is a hand‐held device designed for superior ergonomics, allowing imaging of lesions inaccessible for the 1500 version (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Suspicious skin lesions may also be identified in a referral setting, for example, by a general surgeon, and referred for a consultation with a skin cancer specialist (Figure 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Of the 1051 full text papers assessed, 848 were excluded from all reviews in our series (see Figure 5 PRISMA flow diagram of search and eligibility results).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "There is a description of the various algorithms and thresholds used for diagnosis across the studies in Appendix 7.Methodological quality of included studies\nThe overall methodological quality of all 11 included study cohorts is summarised in Figure 6 and Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Figure 8 gives forest plots of study data for each analysis in this table with studies plotted in ROC space in Figure 9 and Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Table 3 and Figure 11 compare results between observers.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Estimates of sensitivities ranged from 52% to 100% and specificities from 45% to 100% (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The high sensitivity of 100% and low specificity of 45% in Pellacani 2014b (doc) appeared as outliers, all other studies having sensitivities at or below 67% and specificities above 95% (Figure 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Estimates of sensitivities ranged from 85% to 100% and specificities from 76% to 94% (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Sensitivity and specificity estimates were almost identical, with test sensitivity of 85% (95% CI 77% to 91%) for both tests and specificity of 94% (95% CI 89% to 97%) for RCM compared to 92% (95% CI 87% to 96%) for dermoscopy (Table 2; Figure 10).Analyses by algorithms used to assist reflectance confocal microscopy\nThe 11 included cohorts of lesions provided 12 datasets evaluating the accuracy of different approaches to diagnosis with RCM for the detection of BCC.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "These results were largely similar to those of the other studies in 'any suspicious lesion' (Figure 8), all of which reported observers' correct diagnosis of BCC.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "All studies reported sensitivities and specificities at or above 90%, apart from specificities of 78% (95% CI 40% to 97%) reported in Castro 2015, which included only nine 'benign' lesions, and of 78% (95% CI 67% to 87%) in Nori 2004, which reported only that control group lesions had a 'range of common diagnoses' to BCC (Figure 8).Analyses by observer experience\nThe 11 included studies provided 19 datasets evaluating the accuracy of observers with different levels of expertise; nine datasets coming from the same study (Farnetani 2015).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Figure 11 provides forest plots of all studies by observer experience, separately for in‐person and image‐based studies.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Specificities were more variable (45% to 98%), likely due to variations in the spectrum of disease (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Table 4 presents study results and Figure 12 presents forest plots of study data.",
    "figure_references": [
      {
        "figure_number": "Figure 12",
        "panel": "",
        "figure_key": "figure_12"
      }
    ]
  },
  {
    "sentence": "Table 5 present study results and Figure 13 presents forest plots of study data.",
    "figure_references": [
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      }
    ]
  },
  {
    "sentence": "Despite differences in the spectrum of included lesions, results from the two studies were similar (Figure 13), and pooled sensitivity was 89% (95% CI 0.82% to 0.94%) and specificity was 85% (95% CI 75% to 92%).",
    "figure_references": [
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      },
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      }
    ]
  },
  {
    "sentence": "Figure 14 and Figure 15 demonstrate the trade‐off between higher sensitivity and lower specificity from the lower excision threshold.",
    "figure_references": [
      {
        "figure_number": "Figure 14",
        "panel": "",
        "figure_key": "figure_14"
      },
      {
        "figure_number": "Figure 15",
        "panel": "",
        "figure_key": "figure_15"
      }
    ]
  },
  {
    "sentence": "Appendix 8 provides summary characteristics of studies, with forest plots in Figure 8 and ROC plots in Figure 9.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Growth is usually localised, but it can infiltrate and damage surrounding tissue, which if left untreated can cause considerable destruction and disfigurement, particularly when located on the face (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "People with cSCC often present with an ulcer or firm (indurated) papule, plaque, or nodule (Griffin 2016), often with an adherent crust (Madan 2010) (Figure 1). cSCC can arise in the absence of a precursor lesion or may develop from pre‐existing lesions, such as actinic keratosis or Bowen's disease (considered by some clinicians to be cSCC in situ) with an estimated annual risk of progression of less than 1% to 20% for newly‐arising lesions (Alam 2001) and 5% for pre‐existing lesions (Kao 1986).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The contrast for the monochrome images produced is achieved by the variation of the optical properties within the skin when illuminated by a near‐infrared light (830 nm) (see Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The Vivascope 1500 (and the previously available 1000 version) is a console‐based unit with a dermoscopic attachment, whereas the Vivascope 3000 is a hand‐held device designed for superior ergonomics, allowing imaging of lesions inaccessible for the 1500 version (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Suspicious skin lesions may also be identified in a referral setting, for example, by a general surgeon, and referred for a consultation with a skin cancer specialist (Figure 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Of the 1051 full text papers assessed, 848 were excluded from all reviews in our series (see Figure 5 PRISMA flow diagram of search and eligibility results).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "There is a description of the various algorithms and thresholds used for diagnosis across the studies in Appendix 7.Methodological quality of included studies\nThe overall methodological quality of all 11 included study cohorts is summarised in Figure 6 and Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Figure 8 gives forest plots of study data for each analysis in this table with studies plotted in ROC space in Figure 9 and Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Table 3 and Figure 11 compare results between observers.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Estimates of sensitivities ranged from 52% to 100% and specificities from 45% to 100% (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The high sensitivity of 100% and low specificity of 45% in Pellacani 2014b (doc) appeared as outliers, all other studies having sensitivities at or below 67% and specificities above 95% (Figure 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Estimates of sensitivities ranged from 85% to 100% and specificities from 76% to 94% (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Sensitivity and specificity estimates were almost identical, with test sensitivity of 85% (95% CI 77% to 91%) for both tests and specificity of 94% (95% CI 89% to 97%) for RCM compared to 92% (95% CI 87% to 96%) for dermoscopy (Table 2; Figure 10).Analyses by algorithms used to assist reflectance confocal microscopy\nThe 11 included cohorts of lesions provided 12 datasets evaluating the accuracy of different approaches to diagnosis with RCM for the detection of BCC.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "These results were largely similar to those of the other studies in 'any suspicious lesion' (Figure 8), all of which reported observers' correct diagnosis of BCC.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "All studies reported sensitivities and specificities at or above 90%, apart from specificities of 78% (95% CI 40% to 97%) reported in Castro 2015, which included only nine 'benign' lesions, and of 78% (95% CI 67% to 87%) in Nori 2004, which reported only that control group lesions had a 'range of common diagnoses' to BCC (Figure 8).Analyses by observer experience\nThe 11 included studies provided 19 datasets evaluating the accuracy of observers with different levels of expertise; nine datasets coming from the same study (Farnetani 2015).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Figure 11 provides forest plots of all studies by observer experience, separately for in‐person and image‐based studies.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Specificities were more variable (45% to 98%), likely due to variations in the spectrum of disease (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Table 4 presents study results and Figure 12 presents forest plots of study data.",
    "figure_references": [
      {
        "figure_number": "Figure 12",
        "panel": "",
        "figure_key": "figure_12"
      }
    ]
  },
  {
    "sentence": "Table 5 present study results and Figure 13 presents forest plots of study data.",
    "figure_references": [
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      }
    ]
  },
  {
    "sentence": "Despite differences in the spectrum of included lesions, results from the two studies were similar (Figure 13), and pooled sensitivity was 89% (95% CI 0.82% to 0.94%) and specificity was 85% (95% CI 75% to 92%).",
    "figure_references": [
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      },
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      }
    ]
  },
  {
    "sentence": "Figure 14 and Figure 15 demonstrate the trade‐off between higher sensitivity and lower specificity from the lower excision threshold.",
    "figure_references": [
      {
        "figure_number": "Figure 14",
        "panel": "",
        "figure_key": "figure_14"
      },
      {
        "figure_number": "Figure 15",
        "panel": "",
        "figure_key": "figure_15"
      }
    ]
  },
  {
    "sentence": "Appendix 8 provides summary characteristics of studies, with forest plots in Figure 8 and ROC plots in Figure 9.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Growth is usually localised, but it can infiltrate and damage surrounding tissue, which if left untreated can cause considerable destruction and disfigurement, particularly when located on the face (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "People with cSCC often present with an ulcer or firm (indurated) papule, plaque, or nodule (Griffin 2016), often with an adherent crust (Madan 2010) (Figure 1). cSCC can arise in the absence of a precursor lesion or may develop from pre‐existing lesions, such as actinic keratosis or Bowen's disease (considered by some clinicians to be cSCC in situ) with an estimated annual risk of progression of less than 1% to 20% for newly‐arising lesions (Alam 2001) and 5% for pre‐existing lesions (Kao 1986).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The contrast for the monochrome images produced is achieved by the variation of the optical properties within the skin when illuminated by a near‐infrared light (830 nm) (see Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The Vivascope 1500 (and the previously available 1000 version) is a console‐based unit with a dermoscopic attachment, whereas the Vivascope 3000 is a hand‐held device designed for superior ergonomics, allowing imaging of lesions inaccessible for the 1500 version (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Suspicious skin lesions may also be identified in a referral setting, for example, by a general surgeon, and referred for a consultation with a skin cancer specialist (Figure 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Of the 1051 full text papers assessed, 848 were excluded from all reviews in our series (see Figure 5 PRISMA flow diagram of search and eligibility results).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "There is a description of the various algorithms and thresholds used for diagnosis across the studies in Appendix 7.Methodological quality of included studies\nThe overall methodological quality of all 11 included study cohorts is summarised in Figure 6 and Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Figure 8 gives forest plots of study data for each analysis in this table with studies plotted in ROC space in Figure 9 and Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Table 3 and Figure 11 compare results between observers.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Estimates of sensitivities ranged from 52% to 100% and specificities from 45% to 100% (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The high sensitivity of 100% and low specificity of 45% in Pellacani 2014b (doc) appeared as outliers, all other studies having sensitivities at or below 67% and specificities above 95% (Figure 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Estimates of sensitivities ranged from 85% to 100% and specificities from 76% to 94% (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Sensitivity and specificity estimates were almost identical, with test sensitivity of 85% (95% CI 77% to 91%) for both tests and specificity of 94% (95% CI 89% to 97%) for RCM compared to 92% (95% CI 87% to 96%) for dermoscopy (Table 2; Figure 10).Analyses by algorithms used to assist reflectance confocal microscopy\nThe 11 included cohorts of lesions provided 12 datasets evaluating the accuracy of different approaches to diagnosis with RCM for the detection of BCC.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "These results were largely similar to those of the other studies in 'any suspicious lesion' (Figure 8), all of which reported observers' correct diagnosis of BCC.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "All studies reported sensitivities and specificities at or above 90%, apart from specificities of 78% (95% CI 40% to 97%) reported in Castro 2015, which included only nine 'benign' lesions, and of 78% (95% CI 67% to 87%) in Nori 2004, which reported only that control group lesions had a 'range of common diagnoses' to BCC (Figure 8).Analyses by observer experience\nThe 11 included studies provided 19 datasets evaluating the accuracy of observers with different levels of expertise; nine datasets coming from the same study (Farnetani 2015).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Figure 11 provides forest plots of all studies by observer experience, separately for in‐person and image‐based studies.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Specificities were more variable (45% to 98%), likely due to variations in the spectrum of disease (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Table 4 presents study results and Figure 12 presents forest plots of study data.",
    "figure_references": [
      {
        "figure_number": "Figure 12",
        "panel": "",
        "figure_key": "figure_12"
      }
    ]
  },
  {
    "sentence": "Table 5 present study results and Figure 13 presents forest plots of study data.",
    "figure_references": [
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      }
    ]
  },
  {
    "sentence": "Despite differences in the spectrum of included lesions, results from the two studies were similar (Figure 13), and pooled sensitivity was 89% (95% CI 0.82% to 0.94%) and specificity was 85% (95% CI 75% to 92%).",
    "figure_references": [
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      },
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      }
    ]
  },
  {
    "sentence": "Figure 14 and Figure 15 demonstrate the trade‐off between higher sensitivity and lower specificity from the lower excision threshold.",
    "figure_references": [
      {
        "figure_number": "Figure 14",
        "panel": "",
        "figure_key": "figure_14"
      },
      {
        "figure_number": "Figure 15",
        "panel": "",
        "figure_key": "figure_15"
      }
    ]
  },
  {
    "sentence": "Appendix 8 provides summary characteristics of studies, with forest plots in Figure 8 and ROC plots in Figure 9.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Growth is usually localised, but it can infiltrate and damage surrounding tissue, which if left untreated can cause considerable destruction and disfigurement, particularly when located on the face (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "People with cSCC often present with an ulcer or firm (indurated) papule, plaque, or nodule (Griffin 2016), often with an adherent crust (Madan 2010) (Figure 1). cSCC can arise in the absence of a precursor lesion or may develop from pre‐existing lesions, such as actinic keratosis or Bowen's disease (considered by some clinicians to be cSCC in situ) with an estimated annual risk of progression of less than 1% to 20% for newly‐arising lesions (Alam 2001) and 5% for pre‐existing lesions (Kao 1986).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The contrast for the monochrome images produced is achieved by the variation of the optical properties within the skin when illuminated by a near‐infrared light (830 nm) (see Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The Vivascope 1500 (and the previously available 1000 version) is a console‐based unit with a dermoscopic attachment, whereas the Vivascope 3000 is a hand‐held device designed for superior ergonomics, allowing imaging of lesions inaccessible for the 1500 version (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Suspicious skin lesions may also be identified in a referral setting, for example, by a general surgeon, and referred for a consultation with a skin cancer specialist (Figure 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Of the 1051 full text papers assessed, 848 were excluded from all reviews in our series (see Figure 5 PRISMA flow diagram of search and eligibility results).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "There is a description of the various algorithms and thresholds used for diagnosis across the studies in Appendix 7.Methodological quality of included studies\nThe overall methodological quality of all 11 included study cohorts is summarised in Figure 6 and Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Figure 8 gives forest plots of study data for each analysis in this table with studies plotted in ROC space in Figure 9 and Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Table 3 and Figure 11 compare results between observers.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Estimates of sensitivities ranged from 52% to 100% and specificities from 45% to 100% (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The high sensitivity of 100% and low specificity of 45% in Pellacani 2014b (doc) appeared as outliers, all other studies having sensitivities at or below 67% and specificities above 95% (Figure 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Estimates of sensitivities ranged from 85% to 100% and specificities from 76% to 94% (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Sensitivity and specificity estimates were almost identical, with test sensitivity of 85% (95% CI 77% to 91%) for both tests and specificity of 94% (95% CI 89% to 97%) for RCM compared to 92% (95% CI 87% to 96%) for dermoscopy (Table 2; Figure 10).Analyses by algorithms used to assist reflectance confocal microscopy\nThe 11 included cohorts of lesions provided 12 datasets evaluating the accuracy of different approaches to diagnosis with RCM for the detection of BCC.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "These results were largely similar to those of the other studies in 'any suspicious lesion' (Figure 8), all of which reported observers' correct diagnosis of BCC.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "All studies reported sensitivities and specificities at or above 90%, apart from specificities of 78% (95% CI 40% to 97%) reported in Castro 2015, which included only nine 'benign' lesions, and of 78% (95% CI 67% to 87%) in Nori 2004, which reported only that control group lesions had a 'range of common diagnoses' to BCC (Figure 8).Analyses by observer experience\nThe 11 included studies provided 19 datasets evaluating the accuracy of observers with different levels of expertise; nine datasets coming from the same study (Farnetani 2015).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Figure 11 provides forest plots of all studies by observer experience, separately for in‐person and image‐based studies.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Specificities were more variable (45% to 98%), likely due to variations in the spectrum of disease (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Table 4 presents study results and Figure 12 presents forest plots of study data.",
    "figure_references": [
      {
        "figure_number": "Figure 12",
        "panel": "",
        "figure_key": "figure_12"
      }
    ]
  },
  {
    "sentence": "Table 5 present study results and Figure 13 presents forest plots of study data.",
    "figure_references": [
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      }
    ]
  },
  {
    "sentence": "Despite differences in the spectrum of included lesions, results from the two studies were similar (Figure 13), and pooled sensitivity was 89% (95% CI 0.82% to 0.94%) and specificity was 85% (95% CI 75% to 92%).",
    "figure_references": [
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      },
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      }
    ]
  },
  {
    "sentence": "Figure 14 and Figure 15 demonstrate the trade‐off between higher sensitivity and lower specificity from the lower excision threshold.",
    "figure_references": [
      {
        "figure_number": "Figure 14",
        "panel": "",
        "figure_key": "figure_14"
      },
      {
        "figure_number": "Figure 15",
        "panel": "",
        "figure_key": "figure_15"
      }
    ]
  },
  {
    "sentence": "Appendix 8 provides summary characteristics of studies, with forest plots in Figure 8 and ROC plots in Figure 9.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Growth is usually localised, but it can infiltrate and damage surrounding tissue, which if left untreated can cause considerable destruction and disfigurement, particularly when located on the face (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "People with cSCC often present with an ulcer or firm (indurated) papule, plaque, or nodule (Griffin 2016), often with an adherent crust (Madan 2010) (Figure 1). cSCC can arise in the absence of a precursor lesion or may develop from pre‐existing lesions, such as actinic keratosis or Bowen's disease (considered by some clinicians to be cSCC in situ) with an estimated annual risk of progression of less than 1% to 20% for newly‐arising lesions (Alam 2001) and 5% for pre‐existing lesions (Kao 1986).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The contrast for the monochrome images produced is achieved by the variation of the optical properties within the skin when illuminated by a near‐infrared light (830 nm) (see Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The Vivascope 1500 (and the previously available 1000 version) is a console‐based unit with a dermoscopic attachment, whereas the Vivascope 3000 is a hand‐held device designed for superior ergonomics, allowing imaging of lesions inaccessible for the 1500 version (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Suspicious skin lesions may also be identified in a referral setting, for example, by a general surgeon, and referred for a consultation with a skin cancer specialist (Figure 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Of the 1051 full text papers assessed, 848 were excluded from all reviews in our series (see Figure 5 PRISMA flow diagram of search and eligibility results).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "There is a description of the various algorithms and thresholds used for diagnosis across the studies in Appendix 7.Methodological quality of included studies\nThe overall methodological quality of all 11 included study cohorts is summarised in Figure 6 and Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Figure 8 gives forest plots of study data for each analysis in this table with studies plotted in ROC space in Figure 9 and Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Table 3 and Figure 11 compare results between observers.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Estimates of sensitivities ranged from 52% to 100% and specificities from 45% to 100% (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The high sensitivity of 100% and low specificity of 45% in Pellacani 2014b (doc) appeared as outliers, all other studies having sensitivities at or below 67% and specificities above 95% (Figure 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Estimates of sensitivities ranged from 85% to 100% and specificities from 76% to 94% (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Sensitivity and specificity estimates were almost identical, with test sensitivity of 85% (95% CI 77% to 91%) for both tests and specificity of 94% (95% CI 89% to 97%) for RCM compared to 92% (95% CI 87% to 96%) for dermoscopy (Table 2; Figure 10).Analyses by algorithms used to assist reflectance confocal microscopy\nThe 11 included cohorts of lesions provided 12 datasets evaluating the accuracy of different approaches to diagnosis with RCM for the detection of BCC.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "These results were largely similar to those of the other studies in 'any suspicious lesion' (Figure 8), all of which reported observers' correct diagnosis of BCC.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "All studies reported sensitivities and specificities at or above 90%, apart from specificities of 78% (95% CI 40% to 97%) reported in Castro 2015, which included only nine 'benign' lesions, and of 78% (95% CI 67% to 87%) in Nori 2004, which reported only that control group lesions had a 'range of common diagnoses' to BCC (Figure 8).Analyses by observer experience\nThe 11 included studies provided 19 datasets evaluating the accuracy of observers with different levels of expertise; nine datasets coming from the same study (Farnetani 2015).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Figure 11 provides forest plots of all studies by observer experience, separately for in‐person and image‐based studies.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Specificities were more variable (45% to 98%), likely due to variations in the spectrum of disease (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Table 4 presents study results and Figure 12 presents forest plots of study data.",
    "figure_references": [
      {
        "figure_number": "Figure 12",
        "panel": "",
        "figure_key": "figure_12"
      }
    ]
  },
  {
    "sentence": "Table 5 present study results and Figure 13 presents forest plots of study data.",
    "figure_references": [
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      }
    ]
  },
  {
    "sentence": "Despite differences in the spectrum of included lesions, results from the two studies were similar (Figure 13), and pooled sensitivity was 89% (95% CI 0.82% to 0.94%) and specificity was 85% (95% CI 75% to 92%).",
    "figure_references": [
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      },
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      }
    ]
  },
  {
    "sentence": "Figure 14 and Figure 15 demonstrate the trade‐off between higher sensitivity and lower specificity from the lower excision threshold.",
    "figure_references": [
      {
        "figure_number": "Figure 14",
        "panel": "",
        "figure_key": "figure_14"
      },
      {
        "figure_number": "Figure 15",
        "panel": "",
        "figure_key": "figure_15"
      }
    ]
  },
  {
    "sentence": "Appendix 8 provides summary characteristics of studies, with forest plots in Figure 8 and ROC plots in Figure 9.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Growth is usually localised, but it can infiltrate and damage surrounding tissue, which if left untreated can cause considerable destruction and disfigurement, particularly when located on the face (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "People with cSCC often present with an ulcer or firm (indurated) papule, plaque, or nodule (Griffin 2016), often with an adherent crust (Madan 2010) (Figure 1). cSCC can arise in the absence of a precursor lesion or may develop from pre‐existing lesions, such as actinic keratosis or Bowen's disease (considered by some clinicians to be cSCC in situ) with an estimated annual risk of progression of less than 1% to 20% for newly‐arising lesions (Alam 2001) and 5% for pre‐existing lesions (Kao 1986).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The contrast for the monochrome images produced is achieved by the variation of the optical properties within the skin when illuminated by a near‐infrared light (830 nm) (see Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The Vivascope 1500 (and the previously available 1000 version) is a console‐based unit with a dermoscopic attachment, whereas the Vivascope 3000 is a hand‐held device designed for superior ergonomics, allowing imaging of lesions inaccessible for the 1500 version (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Suspicious skin lesions may also be identified in a referral setting, for example, by a general surgeon, and referred for a consultation with a skin cancer specialist (Figure 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Of the 1051 full text papers assessed, 848 were excluded from all reviews in our series (see Figure 5 PRISMA flow diagram of search and eligibility results).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "There is a description of the various algorithms and thresholds used for diagnosis across the studies in Appendix 7.Methodological quality of included studies\nThe overall methodological quality of all 11 included study cohorts is summarised in Figure 6 and Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Figure 8 gives forest plots of study data for each analysis in this table with studies plotted in ROC space in Figure 9 and Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Table 3 and Figure 11 compare results between observers.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Estimates of sensitivities ranged from 52% to 100% and specificities from 45% to 100% (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The high sensitivity of 100% and low specificity of 45% in Pellacani 2014b (doc) appeared as outliers, all other studies having sensitivities at or below 67% and specificities above 95% (Figure 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Estimates of sensitivities ranged from 85% to 100% and specificities from 76% to 94% (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Sensitivity and specificity estimates were almost identical, with test sensitivity of 85% (95% CI 77% to 91%) for both tests and specificity of 94% (95% CI 89% to 97%) for RCM compared to 92% (95% CI 87% to 96%) for dermoscopy (Table 2; Figure 10).Analyses by algorithms used to assist reflectance confocal microscopy\nThe 11 included cohorts of lesions provided 12 datasets evaluating the accuracy of different approaches to diagnosis with RCM for the detection of BCC.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "These results were largely similar to those of the other studies in 'any suspicious lesion' (Figure 8), all of which reported observers' correct diagnosis of BCC.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "All studies reported sensitivities and specificities at or above 90%, apart from specificities of 78% (95% CI 40% to 97%) reported in Castro 2015, which included only nine 'benign' lesions, and of 78% (95% CI 67% to 87%) in Nori 2004, which reported only that control group lesions had a 'range of common diagnoses' to BCC (Figure 8).Analyses by observer experience\nThe 11 included studies provided 19 datasets evaluating the accuracy of observers with different levels of expertise; nine datasets coming from the same study (Farnetani 2015).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Figure 11 provides forest plots of all studies by observer experience, separately for in‐person and image‐based studies.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Specificities were more variable (45% to 98%), likely due to variations in the spectrum of disease (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Table 4 presents study results and Figure 12 presents forest plots of study data.",
    "figure_references": [
      {
        "figure_number": "Figure 12",
        "panel": "",
        "figure_key": "figure_12"
      }
    ]
  },
  {
    "sentence": "Table 5 present study results and Figure 13 presents forest plots of study data.",
    "figure_references": [
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      }
    ]
  },
  {
    "sentence": "Despite differences in the spectrum of included lesions, results from the two studies were similar (Figure 13), and pooled sensitivity was 89% (95% CI 0.82% to 0.94%) and specificity was 85% (95% CI 75% to 92%).",
    "figure_references": [
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      },
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      }
    ]
  },
  {
    "sentence": "Figure 14 and Figure 15 demonstrate the trade‐off between higher sensitivity and lower specificity from the lower excision threshold.",
    "figure_references": [
      {
        "figure_number": "Figure 14",
        "panel": "",
        "figure_key": "figure_14"
      },
      {
        "figure_number": "Figure 15",
        "panel": "",
        "figure_key": "figure_15"
      }
    ]
  },
  {
    "sentence": "Appendix 8 provides summary characteristics of studies, with forest plots in Figure 8 and ROC plots in Figure 9.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Growth is usually localised, but it can infiltrate and damage surrounding tissue, which if left untreated can cause considerable destruction and disfigurement, particularly when located on the face (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "People with cSCC often present with an ulcer or firm (indurated) papule, plaque, or nodule (Griffin 2016), often with an adherent crust (Madan 2010) (Figure 1). cSCC can arise in the absence of a precursor lesion or may develop from pre‐existing lesions, such as actinic keratosis or Bowen's disease (considered by some clinicians to be cSCC in situ) with an estimated annual risk of progression of less than 1% to 20% for newly‐arising lesions (Alam 2001) and 5% for pre‐existing lesions (Kao 1986).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The contrast for the monochrome images produced is achieved by the variation of the optical properties within the skin when illuminated by a near‐infrared light (830 nm) (see Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The Vivascope 1500 (and the previously available 1000 version) is a console‐based unit with a dermoscopic attachment, whereas the Vivascope 3000 is a hand‐held device designed for superior ergonomics, allowing imaging of lesions inaccessible for the 1500 version (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Suspicious skin lesions may also be identified in a referral setting, for example, by a general surgeon, and referred for a consultation with a skin cancer specialist (Figure 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Of the 1051 full text papers assessed, 848 were excluded from all reviews in our series (see Figure 5 PRISMA flow diagram of search and eligibility results).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "There is a description of the various algorithms and thresholds used for diagnosis across the studies in Appendix 7.Methodological quality of included studies\nThe overall methodological quality of all 11 included study cohorts is summarised in Figure 6 and Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Figure 8 gives forest plots of study data for each analysis in this table with studies plotted in ROC space in Figure 9 and Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Table 3 and Figure 11 compare results between observers.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Estimates of sensitivities ranged from 52% to 100% and specificities from 45% to 100% (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The high sensitivity of 100% and low specificity of 45% in Pellacani 2014b (doc) appeared as outliers, all other studies having sensitivities at or below 67% and specificities above 95% (Figure 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Estimates of sensitivities ranged from 85% to 100% and specificities from 76% to 94% (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Sensitivity and specificity estimates were almost identical, with test sensitivity of 85% (95% CI 77% to 91%) for both tests and specificity of 94% (95% CI 89% to 97%) for RCM compared to 92% (95% CI 87% to 96%) for dermoscopy (Table 2; Figure 10).Analyses by algorithms used to assist reflectance confocal microscopy\nThe 11 included cohorts of lesions provided 12 datasets evaluating the accuracy of different approaches to diagnosis with RCM for the detection of BCC.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "These results were largely similar to those of the other studies in 'any suspicious lesion' (Figure 8), all of which reported observers' correct diagnosis of BCC.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "All studies reported sensitivities and specificities at or above 90%, apart from specificities of 78% (95% CI 40% to 97%) reported in Castro 2015, which included only nine 'benign' lesions, and of 78% (95% CI 67% to 87%) in Nori 2004, which reported only that control group lesions had a 'range of common diagnoses' to BCC (Figure 8).Analyses by observer experience\nThe 11 included studies provided 19 datasets evaluating the accuracy of observers with different levels of expertise; nine datasets coming from the same study (Farnetani 2015).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Figure 11 provides forest plots of all studies by observer experience, separately for in‐person and image‐based studies.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Specificities were more variable (45% to 98%), likely due to variations in the spectrum of disease (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Table 4 presents study results and Figure 12 presents forest plots of study data.",
    "figure_references": [
      {
        "figure_number": "Figure 12",
        "panel": "",
        "figure_key": "figure_12"
      }
    ]
  },
  {
    "sentence": "Table 5 present study results and Figure 13 presents forest plots of study data.",
    "figure_references": [
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      }
    ]
  },
  {
    "sentence": "Despite differences in the spectrum of included lesions, results from the two studies were similar (Figure 13), and pooled sensitivity was 89% (95% CI 0.82% to 0.94%) and specificity was 85% (95% CI 75% to 92%).",
    "figure_references": [
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      },
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      }
    ]
  },
  {
    "sentence": "Figure 14 and Figure 15 demonstrate the trade‐off between higher sensitivity and lower specificity from the lower excision threshold.",
    "figure_references": [
      {
        "figure_number": "Figure 14",
        "panel": "",
        "figure_key": "figure_14"
      },
      {
        "figure_number": "Figure 15",
        "panel": "",
        "figure_key": "figure_15"
      }
    ]
  },
  {
    "sentence": "Appendix 8 provides summary characteristics of studies, with forest plots in Figure 8 and ROC plots in Figure 9.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Growth is usually localised, but it can infiltrate and damage surrounding tissue, which if left untreated can cause considerable destruction and disfigurement, particularly when located on the face (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "People with cSCC often present with an ulcer or firm (indurated) papule, plaque, or nodule (Griffin 2016), often with an adherent crust (Madan 2010) (Figure 1). cSCC can arise in the absence of a precursor lesion or may develop from pre‐existing lesions, such as actinic keratosis or Bowen's disease (considered by some clinicians to be cSCC in situ) with an estimated annual risk of progression of less than 1% to 20% for newly‐arising lesions (Alam 2001) and 5% for pre‐existing lesions (Kao 1986).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The contrast for the monochrome images produced is achieved by the variation of the optical properties within the skin when illuminated by a near‐infrared light (830 nm) (see Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The Vivascope 1500 (and the previously available 1000 version) is a console‐based unit with a dermoscopic attachment, whereas the Vivascope 3000 is a hand‐held device designed for superior ergonomics, allowing imaging of lesions inaccessible for the 1500 version (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Suspicious skin lesions may also be identified in a referral setting, for example, by a general surgeon, and referred for a consultation with a skin cancer specialist (Figure 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Of the 1051 full text papers assessed, 848 were excluded from all reviews in our series (see Figure 5 PRISMA flow diagram of search and eligibility results).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "There is a description of the various algorithms and thresholds used for diagnosis across the studies in Appendix 7.Methodological quality of included studies\nThe overall methodological quality of all 11 included study cohorts is summarised in Figure 6 and Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Figure 8 gives forest plots of study data for each analysis in this table with studies plotted in ROC space in Figure 9 and Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Table 3 and Figure 11 compare results between observers.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Estimates of sensitivities ranged from 52% to 100% and specificities from 45% to 100% (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The high sensitivity of 100% and low specificity of 45% in Pellacani 2014b (doc) appeared as outliers, all other studies having sensitivities at or below 67% and specificities above 95% (Figure 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Estimates of sensitivities ranged from 85% to 100% and specificities from 76% to 94% (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Sensitivity and specificity estimates were almost identical, with test sensitivity of 85% (95% CI 77% to 91%) for both tests and specificity of 94% (95% CI 89% to 97%) for RCM compared to 92% (95% CI 87% to 96%) for dermoscopy (Table 2; Figure 10).Analyses by algorithms used to assist reflectance confocal microscopy\nThe 11 included cohorts of lesions provided 12 datasets evaluating the accuracy of different approaches to diagnosis with RCM for the detection of BCC.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "These results were largely similar to those of the other studies in 'any suspicious lesion' (Figure 8), all of which reported observers' correct diagnosis of BCC.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "All studies reported sensitivities and specificities at or above 90%, apart from specificities of 78% (95% CI 40% to 97%) reported in Castro 2015, which included only nine 'benign' lesions, and of 78% (95% CI 67% to 87%) in Nori 2004, which reported only that control group lesions had a 'range of common diagnoses' to BCC (Figure 8).Analyses by observer experience\nThe 11 included studies provided 19 datasets evaluating the accuracy of observers with different levels of expertise; nine datasets coming from the same study (Farnetani 2015).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Figure 11 provides forest plots of all studies by observer experience, separately for in‐person and image‐based studies.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Specificities were more variable (45% to 98%), likely due to variations in the spectrum of disease (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Table 4 presents study results and Figure 12 presents forest plots of study data.",
    "figure_references": [
      {
        "figure_number": "Figure 12",
        "panel": "",
        "figure_key": "figure_12"
      }
    ]
  },
  {
    "sentence": "Table 5 present study results and Figure 13 presents forest plots of study data.",
    "figure_references": [
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      }
    ]
  },
  {
    "sentence": "Despite differences in the spectrum of included lesions, results from the two studies were similar (Figure 13), and pooled sensitivity was 89% (95% CI 0.82% to 0.94%) and specificity was 85% (95% CI 75% to 92%).",
    "figure_references": [
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      },
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      }
    ]
  },
  {
    "sentence": "Figure 14 and Figure 15 demonstrate the trade‐off between higher sensitivity and lower specificity from the lower excision threshold.",
    "figure_references": [
      {
        "figure_number": "Figure 14",
        "panel": "",
        "figure_key": "figure_14"
      },
      {
        "figure_number": "Figure 15",
        "panel": "",
        "figure_key": "figure_15"
      }
    ]
  },
  {
    "sentence": "Appendix 8 provides summary characteristics of studies, with forest plots in Figure 8 and ROC plots in Figure 9.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Growth is usually localised, but it can infiltrate and damage surrounding tissue, which if left untreated can cause considerable destruction and disfigurement, particularly when located on the face (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "People with cSCC often present with an ulcer or firm (indurated) papule, plaque, or nodule (Griffin 2016), often with an adherent crust (Madan 2010) (Figure 1). cSCC can arise in the absence of a precursor lesion or may develop from pre‐existing lesions, such as actinic keratosis or Bowen's disease (considered by some clinicians to be cSCC in situ) with an estimated annual risk of progression of less than 1% to 20% for newly‐arising lesions (Alam 2001) and 5% for pre‐existing lesions (Kao 1986).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The contrast for the monochrome images produced is achieved by the variation of the optical properties within the skin when illuminated by a near‐infrared light (830 nm) (see Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The Vivascope 1500 (and the previously available 1000 version) is a console‐based unit with a dermoscopic attachment, whereas the Vivascope 3000 is a hand‐held device designed for superior ergonomics, allowing imaging of lesions inaccessible for the 1500 version (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Suspicious skin lesions may also be identified in a referral setting, for example, by a general surgeon, and referred for a consultation with a skin cancer specialist (Figure 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Growth is usually localised, but it can infiltrate and damage surrounding tissue, which if left untreated can cause considerable destruction and disfigurement, particularly when located on the face (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "People with cSCC often present with an ulcer or firm (indurated) papule, plaque, or nodule (Griffin 2016), often with an adherent crust (Madan 2010) (Figure 1). cSCC can arise in the absence of a precursor lesion or may develop from pre‐existing lesions, such as actinic keratosis or Bowen's disease (considered by some clinicians to be cSCC in situ) with an estimated annual risk of progression of less than 1% to 20% for newly‐arising lesions (Alam 2001) and 5% for pre‐existing lesions (Kao 1986).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Growth is usually localised, but it can infiltrate and damage surrounding tissue, which if left untreated can cause considerable destruction and disfigurement, particularly when located on the face (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Growth is usually localised, but it can infiltrate and damage surrounding tissue, which if left untreated can cause considerable destruction and disfigurement, particularly when located on the face (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "People with cSCC often present with an ulcer or firm (indurated) papule, plaque, or nodule (Griffin 2016), often with an adherent crust (Madan 2010) (Figure 1). cSCC can arise in the absence of a precursor lesion or may develop from pre‐existing lesions, such as actinic keratosis or Bowen's disease (considered by some clinicians to be cSCC in situ) with an estimated annual risk of progression of less than 1% to 20% for newly‐arising lesions (Alam 2001) and 5% for pre‐existing lesions (Kao 1986).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "People with cSCC often present with an ulcer or firm (indurated) papule, plaque, or nodule (Griffin 2016), often with an adherent crust (Madan 2010) (Figure 1). cSCC can arise in the absence of a precursor lesion or may develop from pre‐existing lesions, such as actinic keratosis or Bowen's disease (considered by some clinicians to be cSCC in situ) with an estimated annual risk of progression of less than 1% to 20% for newly‐arising lesions (Alam 2001) and 5% for pre‐existing lesions (Kao 1986).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The contrast for the monochrome images produced is achieved by the variation of the optical properties within the skin when illuminated by a near‐infrared light (830 nm) (see Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The Vivascope 1500 (and the previously available 1000 version) is a console‐based unit with a dermoscopic attachment, whereas the Vivascope 3000 is a hand‐held device designed for superior ergonomics, allowing imaging of lesions inaccessible for the 1500 version (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The contrast for the monochrome images produced is achieved by the variation of the optical properties within the skin when illuminated by a near‐infrared light (830 nm) (see Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The Vivascope 1500 (and the previously available 1000 version) is a console‐based unit with a dermoscopic attachment, whereas the Vivascope 3000 is a hand‐held device designed for superior ergonomics, allowing imaging of lesions inaccessible for the 1500 version (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Suspicious skin lesions may also be identified in a referral setting, for example, by a general surgeon, and referred for a consultation with a skin cancer specialist (Figure 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Suspicious skin lesions may also be identified in a referral setting, for example, by a general surgeon, and referred for a consultation with a skin cancer specialist (Figure 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Of the 1051 full text papers assessed, 848 were excluded from all reviews in our series (see Figure 5 PRISMA flow diagram of search and eligibility results).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "There is a description of the various algorithms and thresholds used for diagnosis across the studies in Appendix 7.Methodological quality of included studies\nThe overall methodological quality of all 11 included study cohorts is summarised in Figure 6 and Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Figure 8 gives forest plots of study data for each analysis in this table with studies plotted in ROC space in Figure 9 and Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Table 3 and Figure 11 compare results between observers.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Estimates of sensitivities ranged from 52% to 100% and specificities from 45% to 100% (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The high sensitivity of 100% and low specificity of 45% in Pellacani 2014b (doc) appeared as outliers, all other studies having sensitivities at or below 67% and specificities above 95% (Figure 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Estimates of sensitivities ranged from 85% to 100% and specificities from 76% to 94% (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Sensitivity and specificity estimates were almost identical, with test sensitivity of 85% (95% CI 77% to 91%) for both tests and specificity of 94% (95% CI 89% to 97%) for RCM compared to 92% (95% CI 87% to 96%) for dermoscopy (Table 2; Figure 10).Analyses by algorithms used to assist reflectance confocal microscopy\nThe 11 included cohorts of lesions provided 12 datasets evaluating the accuracy of different approaches to diagnosis with RCM for the detection of BCC.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "These results were largely similar to those of the other studies in 'any suspicious lesion' (Figure 8), all of which reported observers' correct diagnosis of BCC.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "All studies reported sensitivities and specificities at or above 90%, apart from specificities of 78% (95% CI 40% to 97%) reported in Castro 2015, which included only nine 'benign' lesions, and of 78% (95% CI 67% to 87%) in Nori 2004, which reported only that control group lesions had a 'range of common diagnoses' to BCC (Figure 8).Analyses by observer experience\nThe 11 included studies provided 19 datasets evaluating the accuracy of observers with different levels of expertise; nine datasets coming from the same study (Farnetani 2015).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Figure 11 provides forest plots of all studies by observer experience, separately for in‐person and image‐based studies.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Specificities were more variable (45% to 98%), likely due to variations in the spectrum of disease (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Table 4 presents study results and Figure 12 presents forest plots of study data.",
    "figure_references": [
      {
        "figure_number": "Figure 12",
        "panel": "",
        "figure_key": "figure_12"
      }
    ]
  },
  {
    "sentence": "Table 5 present study results and Figure 13 presents forest plots of study data.",
    "figure_references": [
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      }
    ]
  },
  {
    "sentence": "Despite differences in the spectrum of included lesions, results from the two studies were similar (Figure 13), and pooled sensitivity was 89% (95% CI 0.82% to 0.94%) and specificity was 85% (95% CI 75% to 92%).",
    "figure_references": [
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      },
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      }
    ]
  },
  {
    "sentence": "Figure 14 and Figure 15 demonstrate the trade‐off between higher sensitivity and lower specificity from the lower excision threshold.",
    "figure_references": [
      {
        "figure_number": "Figure 14",
        "panel": "",
        "figure_key": "figure_14"
      },
      {
        "figure_number": "Figure 15",
        "panel": "",
        "figure_key": "figure_15"
      }
    ]
  },
  {
    "sentence": "Appendix 8 provides summary characteristics of studies, with forest plots in Figure 8 and ROC plots in Figure 9.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Of the 1051 full text papers assessed, 848 were excluded from all reviews in our series (see Figure 5 PRISMA flow diagram of search and eligibility results).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Of the 1051 full text papers assessed, 848 were excluded from all reviews in our series (see Figure 5 PRISMA flow diagram of search and eligibility results).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Methodological quality of included studies\nThe overall methodological quality of all 11 included study cohorts is summarised in Figure 6 and Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The overall methodological quality of all 11 included study cohorts is summarised in Figure 6 and Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Figure 8 gives forest plots of study data for each analysis in this table with studies plotted in ROC space in Figure 9 and Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Table 3 and Figure 11 compare results between observers.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Estimates of sensitivities ranged from 52% to 100% and specificities from 45% to 100% (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The high sensitivity of 100% and low specificity of 45% in Pellacani 2014b (doc) appeared as outliers, all other studies having sensitivities at or below 67% and specificities above 95% (Figure 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Estimates of sensitivities ranged from 85% to 100% and specificities from 76% to 94% (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Sensitivity and specificity estimates were almost identical, with test sensitivity of 85% (95% CI 77% to 91%) for both tests and specificity of 94% (95% CI 89% to 97%) for RCM compared to 92% (95% CI 87% to 96%) for dermoscopy (Table 2; Figure 10).Analyses by algorithms used to assist reflectance confocal microscopy\nThe 11 included cohorts of lesions provided 12 datasets evaluating the accuracy of different approaches to diagnosis with RCM for the detection of BCC.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "These results were largely similar to those of the other studies in 'any suspicious lesion' (Figure 8), all of which reported observers' correct diagnosis of BCC.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "All studies reported sensitivities and specificities at or above 90%, apart from specificities of 78% (95% CI 40% to 97%) reported in Castro 2015, which included only nine 'benign' lesions, and of 78% (95% CI 67% to 87%) in Nori 2004, which reported only that control group lesions had a 'range of common diagnoses' to BCC (Figure 8).Analyses by observer experience\nThe 11 included studies provided 19 datasets evaluating the accuracy of observers with different levels of expertise; nine datasets coming from the same study (Farnetani 2015).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Figure 11 provides forest plots of all studies by observer experience, separately for in‐person and image‐based studies.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Specificities were more variable (45% to 98%), likely due to variations in the spectrum of disease (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Table 4 presents study results and Figure 12 presents forest plots of study data.",
    "figure_references": [
      {
        "figure_number": "Figure 12",
        "panel": "",
        "figure_key": "figure_12"
      }
    ]
  },
  {
    "sentence": "Table 5 present study results and Figure 13 presents forest plots of study data.",
    "figure_references": [
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      }
    ]
  },
  {
    "sentence": "Despite differences in the spectrum of included lesions, results from the two studies were similar (Figure 13), and pooled sensitivity was 89% (95% CI 0.82% to 0.94%) and specificity was 85% (95% CI 75% to 92%).",
    "figure_references": [
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      },
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      }
    ]
  },
  {
    "sentence": "Figure 14 and Figure 15 demonstrate the trade‐off between higher sensitivity and lower specificity from the lower excision threshold.",
    "figure_references": [
      {
        "figure_number": "Figure 14",
        "panel": "",
        "figure_key": "figure_14"
      },
      {
        "figure_number": "Figure 15",
        "panel": "",
        "figure_key": "figure_15"
      }
    ]
  },
  {
    "sentence": "Appendix 8 provides summary characteristics of studies, with forest plots in Figure 8 and ROC plots in Figure 9.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Figure 8 gives forest plots of study data for each analysis in this table with studies plotted in ROC space in Figure 9 and Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Table 3 and Figure 11 compare results between observers.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Estimates of sensitivities ranged from 52% to 100% and specificities from 45% to 100% (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The high sensitivity of 100% and low specificity of 45% in Pellacani 2014b (doc) appeared as outliers, all other studies having sensitivities at or below 67% and specificities above 95% (Figure 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Estimates of sensitivities ranged from 85% to 100% and specificities from 76% to 94% (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Sensitivity and specificity estimates were almost identical, with test sensitivity of 85% (95% CI 77% to 91%) for both tests and specificity of 94% (95% CI 89% to 97%) for RCM compared to 92% (95% CI 87% to 96%) for dermoscopy (Table 2; Figure 10).Analyses by algorithms used to assist reflectance confocal microscopy\nThe 11 included cohorts of lesions provided 12 datasets evaluating the accuracy of different approaches to diagnosis with RCM for the detection of BCC.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "These results were largely similar to those of the other studies in 'any suspicious lesion' (Figure 8), all of which reported observers' correct diagnosis of BCC.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "All studies reported sensitivities and specificities at or above 90%, apart from specificities of 78% (95% CI 40% to 97%) reported in Castro 2015, which included only nine 'benign' lesions, and of 78% (95% CI 67% to 87%) in Nori 2004, which reported only that control group lesions had a 'range of common diagnoses' to BCC (Figure 8).Analyses by observer experience\nThe 11 included studies provided 19 datasets evaluating the accuracy of observers with different levels of expertise; nine datasets coming from the same study (Farnetani 2015).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Figure 11 provides forest plots of all studies by observer experience, separately for in‐person and image‐based studies.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Specificities were more variable (45% to 98%), likely due to variations in the spectrum of disease (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Figure 8 gives forest plots of study data for each analysis in this table with studies plotted in ROC space in Figure 9 and Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Table 3 and Figure 11 compare results between observers.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Estimates of sensitivities ranged from 52% to 100% and specificities from 45% to 100% (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The high sensitivity of 100% and low specificity of 45% in Pellacani 2014b (doc) appeared as outliers, all other studies having sensitivities at or below 67% and specificities above 95% (Figure 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Estimates of sensitivities ranged from 52% to 100% and specificities from 45% to 100% (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The high sensitivity of 100% and low specificity of 45% in Pellacani 2014b (doc) appeared as outliers, all other studies having sensitivities at or below 67% and specificities above 95% (Figure 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Estimates of sensitivities ranged from 85% to 100% and specificities from 76% to 94% (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Sensitivity and specificity estimates were almost identical, with test sensitivity of 85% (95% CI 77% to 91%) for both tests and specificity of 94% (95% CI 89% to 97%) for RCM compared to 92% (95% CI 87% to 96%) for dermoscopy (Table 2; Figure 10).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Estimates of sensitivities ranged from 85% to 100% and specificities from 76% to 94% (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Sensitivity and specificity estimates were almost identical, with test sensitivity of 85% (95% CI 77% to 91%) for both tests and specificity of 94% (95% CI 89% to 97%) for RCM compared to 92% (95% CI 87% to 96%) for dermoscopy (Table 2; Figure 10).",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "These results were largely similar to those of the other studies in 'any suspicious lesion' (Figure 8), all of which reported observers' correct diagnosis of BCC.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "All studies reported sensitivities and specificities at or above 90%, apart from specificities of 78% (95% CI 40% to 97%) reported in Castro 2015, which included only nine 'benign' lesions, and of 78% (95% CI 67% to 87%) in Nori 2004, which reported only that control group lesions had a 'range of common diagnoses' to BCC (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "These results were largely similar to those of the other studies in 'any suspicious lesion' (Figure 8), all of which reported observers' correct diagnosis of BCC.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "All studies reported sensitivities and specificities at or above 90%, apart from specificities of 78% (95% CI 40% to 97%) reported in Castro 2015, which included only nine 'benign' lesions, and of 78% (95% CI 67% to 87%) in Nori 2004, which reported only that control group lesions had a 'range of common diagnoses' to BCC (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Figure 11 provides forest plots of all studies by observer experience, separately for in‐person and image‐based studies.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Specificities were more variable (45% to 98%), likely due to variations in the spectrum of disease (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Figure 11 provides forest plots of all studies by observer experience, separately for in‐person and image‐based studies.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Specificities were more variable (45% to 98%), likely due to variations in the spectrum of disease (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Table 4 presents study results and Figure 12 presents forest plots of study data.",
    "figure_references": [
      {
        "figure_number": "Figure 12",
        "panel": "",
        "figure_key": "figure_12"
      }
    ]
  },
  {
    "sentence": "Table 4 presents study results and Figure 12 presents forest plots of study data.",
    "figure_references": [
      {
        "figure_number": "Figure 12",
        "panel": "",
        "figure_key": "figure_12"
      }
    ]
  },
  {
    "sentence": "Table 5 present study results and Figure 13 presents forest plots of study data.",
    "figure_references": [
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      }
    ]
  },
  {
    "sentence": "Despite differences in the spectrum of included lesions, results from the two studies were similar (Figure 13), and pooled sensitivity was 89% (95% CI 0.82% to 0.94%) and specificity was 85% (95% CI 75% to 92%).",
    "figure_references": [
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      },
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      }
    ]
  },
  {
    "sentence": "Figure 14 and Figure 15 demonstrate the trade‐off between higher sensitivity and lower specificity from the lower excision threshold.",
    "figure_references": [
      {
        "figure_number": "Figure 14",
        "panel": "",
        "figure_key": "figure_14"
      },
      {
        "figure_number": "Figure 15",
        "panel": "",
        "figure_key": "figure_15"
      }
    ]
  },
  {
    "sentence": "Table 5 present study results and Figure 13 presents forest plots of study data.",
    "figure_references": [
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      }
    ]
  },
  {
    "sentence": "Despite differences in the spectrum of included lesions, results from the two studies were similar (Figure 13), and pooled sensitivity was 89% (95% CI 0.82% to 0.94%) and specificity was 85% (95% CI 75% to 92%).",
    "figure_references": [
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      },
      {
        "figure_number": "Figure 13",
        "panel": "",
        "figure_key": "figure_13"
      }
    ]
  },
  {
    "sentence": "Figure 14 and Figure 15 demonstrate the trade‐off between higher sensitivity and lower specificity from the lower excision threshold.",
    "figure_references": [
      {
        "figure_number": "Figure 14",
        "panel": "",
        "figure_key": "figure_14"
      },
      {
        "figure_number": "Figure 15",
        "panel": "",
        "figure_key": "figure_15"
      }
    ]
  },
  {
    "sentence": "Appendix 8 provides summary characteristics of studies, with forest plots in Figure 8 and ROC plots in Figure 9.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Appendix 8 provides summary characteristics of studies, with forest plots in Figure 8 and ROC plots in Figure 9.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  }
]